Mechanistic study reveals SADS-CoV nucleocapsid evasion of DAD1-mediated STING activation in host cells, highlighting potential therapeutic targets for coronavirus infections.
The STING pathway is pivotal in defense against RNA viruses; however, its involvement in swine acute diarrhea syndrome coronavirus (SADS-CoV) infection remains unclear. This study reveals a dual mechanism where in SADS-CoV triggers STING activation via nuclear envelope rupture but subsequently evades immunity through its nucleocapsid (N) protein. Mechanistically, this process involves chromatin leakage that activates the cGAS-STING pathway, triggering interferon responses. The endoplasmic reticulum-resident protein defender against cell death 1 (DAD1) plays a key role in promoting STING phosphorylation and trafficking to the Golgi apparatus. The SADS-CoV N protein binds to STING to block its activation and translocation, disrupting DAD1-mediated antiviral signaling. Notably, the E368A mutation in the N protein weakens STING binding and impairs immune suppression. These findings reveal that the SADS-CoV N protein evades host innate immunity by disrupting DAD1-mediated activation, pointing to potential targets for antiviral strategies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: